Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands		Total	Common Shares	Class B Common Stock	Common Stock Common Shares	Common Stock Class B Common Stock	Capital Surplus	Retained Earnings	Retained Earnings Common Shares	Retained Earnings Class B Common Stock	Accumulated Other Comprehensive Loss
Balance at beginning of period at Aug. 26, 2023		$ 2,003,960			$ 1,510	$ 359	$ 99,303	$ 1,926,549			$ (23,761)
Balance at beginning as of period (in shares) at Aug. 26, 2023					15,104,000	3,590,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		42,325						42,325
Change in fair value of derivatives	[1]	(12)									(12)
Foreign currency translation		(151)									(151)
Dividends declared Common Stock			$ (4,993)	$ (948)					$ (4,993)	$ (948)
Repurchase of Common Stock		(255)					(10)	(245)
Repurchase of common stock (in shares)					(2)
Share-based compensation, net	[2]	244					244
Share-based awards exercised, net	[1]	3			$ 3
Share-based awards exercised, net (in shares)	[1]				26,000
Balance at end of period at Nov. 25, 2023		2,040,173			$ 1,513	$ 359	99,537	1,962,688			(23,924)
Balance at end as of period (in shares) at Nov. 25, 2023					15,128,000	3,590,000
Balance at beginning of period at Aug. 26, 2023		2,003,960			$ 1,510	$ 359	99,303	1,926,549			(23,761)
Balance at beginning as of period (in shares) at Aug. 26, 2023					15,104,000	3,590,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		62,782
Foreign currency translation		768
Balance at end of period at Feb. 24, 2024		2,049,685			$ 1,509	$ 359	101,197	1,969,659			(23,039)
Balance at end as of period (in shares) at Feb. 24, 2024					15,087	3,590
Balance at beginning of period at Nov. 25, 2023		2,040,173			$ 1,513	$ 359	99,537	1,962,688			(23,924)
Balance at beginning as of period (in shares) at Nov. 25, 2023					15,128,000	3,590,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		20,457						20,457
Change in fair value of derivatives	[1]	(34)									(34)
Foreign currency translation		919									919
Dividends declared Common Stock			(4,976)	(948)					(4,976)	(948)
Repurchase of Common Stock		(7,864)			$ (4)		(298)	(7,562)
Repurchase of common stock (in shares)					(45)
Share-based compensation, net	[2]	1,958					1,958
Share-based awards exercised, net (in shares)	[1]				4
Balance at end of period at Feb. 24, 2024		2,049,685			$ 1,509	$ 359	101,197	1,969,659			(23,039)
Balance at end as of period (in shares) at Feb. 24, 2024					15,087	3,590
Balance at beginning of period at Aug. 31, 2024		2,108,511			$ 1,500	$ 359	104,791	2,025,505			(23,644)
Balance at beginning as of period (in shares) at Aug. 31, 2024					15,000,000	3,590,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		43,105						43,105
Change in fair value of derivatives	[1]	41									41
Foreign currency translation		(4,936)									(4,936)
Dividends declared Common Stock			(5,260)	(996)					(5,260)	(996)
Repurchase of Common Stock		(6,373)			$ (3)		(235)	(6,135)
Repurchase of common stock (in shares)					(34,000)
Share-based compensation, net	[2]	(448)					(448)
Share-based awards exercised, net	[1]	3			$ 3
Share-based awards exercised, net (in shares)	[1]				33,000
Shares converted					$ 3	$ (3)
Shares converted (in shares)					32,000	(32,000)
Balance at end of period at Nov. 30, 2024		2,133,647			$ 1,503	$ 356	104,108	2,056,219			(28,539)
Balance at end as of period (in shares) at Nov. 30, 2024					15,031,000	3,558,000
Balance at beginning of period at Aug. 31, 2024		2,108,511			$ 1,500	$ 359	104,791	2,025,505			(23,644)
Balance at beginning as of period (in shares) at Aug. 31, 2024					15,000,000	3,590,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		67,564
Foreign currency translation		(9,374)
Balance at end of period at Mar. 01, 2025		2,143,556			$ 1,501	$ 356	106,141	2,068,510			(32,952)
Balance at end as of period (in shares) at Mar. 01, 2025					15,006	3,558
Balance at beginning of period at Nov. 30, 2024		2,133,647			$ 1,503	$ 356	104,108	2,056,219			(28,539)
Balance at beginning as of period (in shares) at Nov. 30, 2024					15,031,000	3,558,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		24,459						24,459
Change in fair value of derivatives	[1]	25									25
Foreign currency translation		(4,438)									(4,438)
Dividends declared Common Stock			$ (5,251)	$ (996)					$ (5,251)	$ (996)
Repurchase of Common Stock		(6,155)			$ (3)		(231)	(5,921)
Repurchase of common stock (in shares)					(33)
Share-based compensation, net	[2]	2,264					2,264
Share-based awards exercised, net	[1]	1			$ 1
Share-based awards exercised, net (in shares)	[1]				8
Balance at end of period at Mar. 01, 2025		$ 2,143,556			$ 1,501	$ 356	$ 106,141	$ 2,068,510			$ (32,952)
Balance at end as of period (in shares) at Mar. 01, 2025					15,006	3,558

[1] These amounts are shown net of the effect of income taxes.

[2] These amounts are shown net of any shares withheld by the Company to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.